tiprankstipranks
Trending News
More News >

IPO - New Portfolio

ARAM

IPO
Individual Investor
Ranked #644,831 out of 820,151 TipRanks' Investors
Success Rate
40%
90 out of 228
profitable transactions
Average Return
-13.63%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 1.88%
6-Month Return▲ 22.81%
12-Month Return▲ 2548.74%
YTD Return▲ 210.82%
Total Return▲ 29291.89%

Best Trade

Opened at
Closed at-
Gain▲ 647.58%

Bio

IPO

Performance

27.92%0-27.92%
▼ 12.86%
▼ 1.27%
▼ 3.53%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 8.98%
Mar 2025
▲ 1.84%
▼ 0.87%
▼ 0.99%
Apr 2025
▲ 12.20%
▲ 6.28%
▲ 0.83%
May 2025
▲ 6.24%
▲ 5.14%
▲ 14.09%
Jun 2025
▲ 27.92%
▲ 2.30%
▲ 5.77%
Jul 2025
▲ 4.87%
▲ 2.05%
▲ 4.88%
Aug 2025
▲ 5.67%
▲ 2.30%
▲ 1.62%
Sep 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 12.86%▼ 1.27%▼ 3.53%
▼ 1.80%▼ 5.57%▼ 8.98%
▲ 1.84%▼ 0.87%▼ 0.99%
▲ 12.20%▲ 6.28%▲ 0.83%
▲ 6.24%▲ 5.14%▲ 14.09%
▲ 27.92%▲ 2.30%▲ 5.77%
▲ 4.87%▲ 2.05%▲ 4.88%
▲ 5.67%▲ 2.30%▲ 1.62%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Omega Therapeutics
▼ 99.88%
2
Close
Aug 11, 2025
Verve Therapeutics
▼ 76.68%
2
Close
Jul 24, 2025
Akoya Biosciences
▼ 94.42%
2
Close
Jul 07, 2025
Quanterix
0.01%
▼ 16.51%
1
Open
Jul 07, 2025
Achilles Therapeutics
▼ 82.35%
3
Close
Mar 20, 2025
HashiCorp
▼ 59.55%
2
Close
Feb 26, 2025
Vroom
▼ 99.87%
2
Close
Jan 14, 2025
VIZIO Holding
▼ 47.96%
2
Close
Dec 02, 2024
Recursion Pharmaceuticals
0.09%
▼ 55.35%
2
Buy
Nov 19, 2024
Exscientia Plc
▼ 80.84%
2
Close
Nov 19, 2024
Thoughtworks Holding
▼ 85.00%
2
Close
Nov 12, 2024
Sterling Check
▼ 37.12%
2
Close
Oct 30, 2024
First Advantage
0.13%
▼ 20.43%
1
Open
Oct 30, 2024
WalkMe
▼ 53.69%
2
Close
Sep 11, 2024
Fusion Pharmaceuticals
▲ 61.30%
2
Close
Jun 03, 2024
Kinnate Biopharma
▼ 94.09%
2
Close
Apr 02, 2024
Gracell Biotechnologies
▼ 40.15%
4
Close
Feb 21, 2024
Rain Oncology
▼ 92.14%
2
Close
Jan 25, 2024
TuSimple Holdings
▼ 97.55%
2
Close
Jan 06, 2024
Oncorus
▼ 91.35%
5
Close
Dec 29, 2023